Skip to main
TCMD

Tactile Systems (TCMD) Stock Forecast & Price Target

Tactile Systems (TCMD) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Tactile Systems Tech is poised for success in the growing market of at-home therapies for chronic conditions, with a strong revenue forecast and a focus on efficiency through process improvement and AI. With a competitive position in both basic and advanced compression markets and a patient-centered approach, the company is well-equipped for future growth and has a projected revenue of $408.5M in the next 12-24 months. Risks such as slow adoption or competition may be present, but overall the company's attractive valuation and promising outlook make it a solid investment opportunity.

Bears say

Tactile Systems Tech is benefitting from the Medicare NCD driving patient visits and indication uptake with increased flexitouch adoption outpacing nimbl. The acquisition of LymphaTech is providing a boost, bringing in additional revenue streams with its innovative solution for diagnosing and documenting lymphatic fluid. However, this bullish outlook is counterbalanced by relatively high operating expenses, as well as uncertain revenue potential from the ongoing integration and development of LymphaTech.

Tactile Systems (TCMD) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tactile Systems (TCMD) Forecast

Analysts have given Tactile Systems (TCMD) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Tactile Systems (TCMD) has a Strong Buy consensus rating as of Jun 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $37.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $37.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tactile Systems (TCMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.